Back to search
FDAFDA · Food and drugs·Recall number D-0297-2015

CYANOCOBALAMIN INJECTION, USP, 1000 mcg/mL, For IM or IV Use, Multiple Dose 2 mL Vials, Rx only. APP Pharmaceuticals, LLC, Schaumburg, IL 60173. NDC: 63323-044-01.

Published December 17, 2014 · Recall initiated: September 27, 2012

Summary

FDA records drug Class II recall D-0297-2015, published December 17, 2014 and initiated September 27, 2012. Recalling firm: Fresenius Kabi USA, LLC; Status: Terminated; Reported quantity: 240,550 Vials; Lot: Lot 6003853, exp. date 04/2014. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.

What to do

Voluntary: Firm initiated · Letter

Get an email if CYANOCOBALAMIN has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
CYANOCOBALAMIN
Manufacturer
Fresenius Kabi USA, LLC
Distributor
U.S. Nationwide Including Puerto Rico
Lot
Lot 6003853, exp. date 04/2014
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was CYANOCOBALAMIN INJECTION, USP, 1000 mcg/mL, For IM or IV Use, Multiple Dose 2 mL Vials, Rx only. APP Pharmaceuticals, LLC, Schaumburg, IL 60173. NDC: 63323-044-01. recalled?

Yes. FDA published recall D-0297-2015 on December 17, 2014. Reported hazard: Lack of Assurance of Sterility: Glass vials may have finish fractures and glass particles.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: CYANOCOBALAMIN.